Oncternal Therapeutics, Inc. (ONCT) financial statements (2022 and earlier)

Company profile

Business Address 12230 EL CAMINO REAL
SAN DIEGO, CA 92130
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments90,765116,73720,05128,45843,89921,869
Cash and cash equivalents90,765116,73720,05128,25815,8168,910
Short-term investments   20028,08312,959
Prepaid expense 1,266    
Other undisclosed current assets2,088 7362,7502,1782,429
Total current assets:92,853118,00320,78731,20846,07724,298
Noncurrent Assets
Operating lease, right-of-use asset7540190
Property, plant and equipment   195181
Intangible assets, net (including goodwill)   94108123
Intangible assets, net (excluding goodwill)   94108123
Other noncurrent assets657766767   
Total noncurrent assets:732806957113159204
TOTAL ASSETS:93,585118,80921,74431,32146,23624,502
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,3904,1853,6023,3452,6071,224
Accounts payable1,9591,1438713,2792,6041,220
Accrued liabilities3,4313,0422,731   
Employee-related liabilities   6634
Debt  99   
Other undisclosed current liabilities751,6733,6401,8655,3683,387
Total current liabilities:5,4655,8587,3415,2107,9754,611
Noncurrent Liabilities
Long-term debt and lease obligation  91   
Operating lease, liability  91
Total noncurrent liabilities:  91   
Total liabilities:5,4655,8587,4325,2107,9754,611
Stockholders' equity
Stockholders' equity attributable to parent88,120112,95114,31226,11138,26119,891
Common stock494915242216
Additional paid in capital202,201195,69979,869626,142599,876551,073
Accumulated deficit(114,130)(82,797)(65,572)(600,055)(561,637)(531,198)
Total stockholders' equity:88,120112,95114,31226,11138,26119,891
TOTAL LIABILITIES AND EQUITY:93,585118,80921,74431,32146,23624,502

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues4,3153,3752,425   
Gross profit:4,3153,3752,425   
Operating expenses(35,681)(20,917)(35,533)(39,059)(30,655)(25,933)
Operating loss:(31,366)(17,542)(33,108)(39,059)(30,655)(25,933)
Nonoperating income (expense)66333(1,080)64121646
Investment income, nonoperating3316    
Other nonoperating income (expense)33317(1,080)64121646
Loss before gain (loss) on sale of properties:(31,300)(17,209)(34,188)(38,418)(30,439)(25,887)
Other undisclosed net loss(33)(16)    
Net loss:(31,333)(17,225)(34,188)(38,418)(30,439)(25,887)
Other undisclosed net income attributable to parent     8,163
Net loss available to common stockholders, diluted:(31,333)(17,225)(34,188)(38,418)(30,439)(17,724)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(31,333)(17,225)(34,188)(38,418)(30,439)(25,887)
Comprehensive loss, net of tax, attributable to parent:(31,333)(17,225)(34,188)(38,418)(30,439)(25,887)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: